This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2ij7

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2ij7.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2ij7.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2ij7| PDB=2ij7 | SCENE= }}
{{STRUCTURE_2ij7| PDB=2ij7 | SCENE= }}
-
'''Structure of Mycobacterium tuberculosis CYP121 in complex with the antifungal drug fluconazole'''
+
===Structure of Mycobacterium tuberculosis CYP121 in complex with the antifungal drug fluconazole===
-
==Overview==
+
<!--
-
Azole and triazole drugs are cytochrome P450 inhibitors widely used as fungal antibiotics and possessing potent antimycobacterial activity. We present here the crystal structure of Mycobacterium tuberculosis cytochrome P450 CYP121 in complex with the triazole drug fluconazole, revealing a new azole heme ligation mode. In contrast to other structurally characterized cytochrome P450 azole complexes, where the azole nitrogen directly coordinates the heme iron, in CYP121 fluconazole does not displace the aqua sixth heme ligand but occupies a position that allows formation of a direct hydrogen bond to the aqua sixth heme ligand. Direct ligation of fluconazole to the heme iron is observed in a minority of CYP121 molecules, albeit with severe deviations from ideal geometry due to close contacts with active site residues. Analysis of both ligand-on and -off structures reveals the relative position of active site residues derived from the I-helix is a key determinant in the relative ratio of on and off states. Regardless, both ligand-bound states lead to P450 inactivation by active site occlusion. This previously unrecognized means of P450 inactivation is consistent with spectroscopic analyses in both solution and in the crystalline form and raises important questions relating to interaction of azoles with both pathogen and human P450s.
+
The line below this paragraph, {{ABSTRACT_PUBMED_17028183}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 17028183 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_17028183}}
==About this Structure==
==About this Structure==
Line 29: Line 33:
[[Category: P450 cyp121]]
[[Category: P450 cyp121]]
[[Category: Tuberculosis]]
[[Category: Tuberculosis]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 07:33:59 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 16:28:34 2008''

Revision as of 13:28, 29 July 2008

Image:2ij7.png

Template:STRUCTURE 2ij7

Structure of Mycobacterium tuberculosis CYP121 in complex with the antifungal drug fluconazole

Template:ABSTRACT PUBMED 17028183

About this Structure

2IJ7 is a Single protein structure of sequence from Mycobacterium tuberculosis. Full crystallographic information is available from OCA.

Reference

Crystal structure of the Mycobacterium tuberculosis P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode., Seward HE, Roujeinikova A, McLean KJ, Munro AW, Leys D, J Biol Chem. 2006 Dec 22;281(51):39437-43. Epub 2006 Oct 6. PMID:17028183

Page seeded by OCA on Tue Jul 29 16:28:34 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2ij7"
Personal tools